News
News
Australian Patient Advocacy Alliance partners on launch of Patients and patents campaign
In this episode of Arthritis Consumer Experts' Arthritis At Home, host Cheryl Koehn speaks with Deidre Mackechnie, Executive Officer of ...
Proliferating Patents, Lawsuits Stave Off Pharmas’ Generic Competitors
A recent article published on BioSpace summarizes an analysis conducted by Sean Tu of the University of Alabama School of ...
“Canada’s drug access debate has two ends: patients are caught in the middle,” Op-Ed by Arthritis Consumer Experts (ACE)
ACE submitted an Op-Ed to the Globe and Mail, Canada’s national newspaper of record in response to an article focused ...
Gaming the system: An overview of originator companies’ evergreening strategies used to hinder access to generic and biosimilar products
This report from the International Generic and Biosimilar Medicines Association looks at the various strategies ...
Patients and patents campaign partners launch website
Prescription drug prices continue to rise around the world, putting essential medications out of reach for too many people living ...
Interview: Patients and patents – Understanding how pharmaceutical patents affect medication cost
This Arthritis Consumer Experts Arthritis At Home explores why some medications are so expensive and the role pharmaceutical patents play ...
Beyond regulatory delays: How patent misuse impacts access to affordable medications
This Globe and Mail op-ed calls attention to how brand-name manufacturers are using the patent system to block affordable biosimilars ...
How pharmaceutical patents make drugs expensive
In this video, science communicator Patrick Kelly uses engaging visuals and storytelling to explain the pharmaceutical patent system ...